$38.5
Currently 12 wall-street analysts regularly analyze the financials of Protagonist Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 12 analysts offering 12-month price forecasts for Protagonist Therapeutics Inc (PTGX) have a share price target of $58.3. This median of share price forecast represents a 51.43% upside from the latest price of $38.5 as on 06.03.25.
As per the chart shown above, analysts believe that the Protagonist Therapeutics Inc (PTGX) share price will touch around $58.3 in next 12-months.
Below is a chart showing the percentage difference between Protagonist Therapeutics Inc's share price and its median forecast price. As on 06.03.25, the difference is -17.06%
Based on 12 analysts tracking and researching Protagonist Therapeutics Inc (PTGX) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 7 | 7 | 7 |
Outperform | 4 | 4 | 4 |
Hold | 1 | 1 | 1 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |